Skip to main content

Table 2 Potential circulating Exo-miR biomarkers of DN

From: Stem cell-derived and circulating exosomal microRNAs as new potential tools for diabetic nephropathy management

miRs

(exosomal level)

Species

Type of DN

Cell source

Molecular target

Refs

Urinary exosomal miRs

 

miR-145 (+)

Human, mouse, cell

Type 1 DN

Mesangial cell

ND

[156]

miR-15b (+)

miR-34a (+)

miR-636 (+)

Human

Type 2 DN

ND

ND

[164]

miR-4534

Human

Type 2 DN

podocyte

FOXO1

[165]

miR-320c (+)

Human

Type 2 DN

ND

TSP-1

[167]

miR-let-7c-5p (+)

Human

Type 2 DN

ND

TGF-β

[172]

miR-362-3p (+)

miR-877-3p (+)

miR-150-5p (+)

miR-15a-5p (‒)

Human

Type 2 DN

ND

AMPK, p53, mTOR

[163]

miR-21-5p (+)

miR-30b-5p (‒)

Human

Type 2 DN

ND

ND

[175]

miR-15b-5p (+)

Human, mouse, cell

Type 2 DN

Mesangial cell

BCL-2

[166]

miR-188-5p (+)

miR-150-3p (+)

miR-133a-3p (‒)

miR-153-3p (‒)

Human

Nephrotic-range proteinuria

ND

 

[111]

miR-133b (+) miR-342 (+) miR-30a (+)

Human

ND

ND

TGF-β1

[158]

miR-451-5p (+)

Rat

ND

ND

 

[186]

miR-483-5p (+)

Mouse

Type 1 and type 2 DN

Tubular cell

MAPK and TIMP2

[187]

Serum exosomal miRs

miR-4449 (+)

miR- 1246 (+)

miR-642a-3p (+)

let-7c-5p (+)

miR-1255b-5p (+) let-7i-3p (+)

miR-5010-5p (+)

miR-150-3p (+)

Human

ND

ND

MAPK pathway

TGF-β pathway

Integrin-VEGF pathway

Olfactory Pathway

AP-1and NF-κB network

[176] [178]

Exo-miR-29 (+)

Human

Type 1 DN

ND

Serine/threonine-protein kinase WINK3 gene

(181)

  1. (+) and (‒) show upregulation and downregulation, respectively
  2. Not defined, ND; TSP-1, Thrombospondin 1; VEGF, vascular endothelial growth factor; AP-1, activator protein-1; NF-κB, nuclear factor-κB; MAPK, mitogen-activated protein kinase; TGF-β, transforming growth factor beta; DN, diabetic nephropathy; the tissue inhibitor of metalloproteinases 2, TIMP2